Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: Bone graft extenders and substitutes as an adjunct for lumbar fusion
Authors:
- 1 July 2014
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 21 (1) , 106-132
Abstract
In an attempt to enhance the potential to achieve a solid arthrodesis and avoid the morbidity of harvesting autologous iliac crest bone (AICB) for a lumbar fusion, numerous alternatives have been investigated. The use of these fusion adjuncts has become routine despite a lack of convincing evidence demonstrating a benefit to justify added costs or potential harm. Potential alternatives to AICB include locally harvested autograft, calcium-phosphate salts, demineralized bone matrix (DBM), and the family of bone morphogenetic proteins (BMPs). In particular, no option has created greater controversy than the BMPs. A significant increase in the number of publications, particularly with respect to the BMPs, has taken place since the release of the original guidelines. Both DBM and the calciumphosphate salts have demonstrated efficacy as a graft extender or as a substitute for AICB when combined with local autograft. The use of recombinant human BMP-2 (rhBMP-2) as a substitute for AICB, when performing an interbody lumbar fusion, is considered an option since similar outcomes have been observed; however, the potential for heterotopic bone formation is a concern. The use of rhBMP-2, when combined with calcium phosphates, as a substitute for AICB, or as an extender, when used with local autograft or AICB, is also considered an option as similar fusion rates and clinical outcomes have been observed. Surgeons electing to use BMPs should be aware of a growing body of literature demonstrating unique complications associated with the use of BMPs.Keywords
This publication has 62 references indexed in Scilit:
- Efficacy of Silicate-Substituted Calcium Phosphate Ceramic in Posterolateral Instrumented Lumbar FusionSpine, 2010
- Bone Morphogenetic Protein-2 and Bone Marrow Aspirate With Allograft as Alternatives to Autograft in Instrumented Revision Posterolateral Lumbar Spinal FusionSpine, 2010
- A Prospective, Randomized, Controlled, Multicenter Study of Osteogenic Protein-1 in Instrumented Posterolateral FusionsSpine, 2010
- The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysisEuropean Spine Journal, 2009
- A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros®‐HA) as a bone graft extenderJournal of Biomedical Materials Research Part A, 2008
- Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up studyInternational Orthopaedics, 2008
- Outcomes of bone morphogenetic protein-2 in mature adults: posterolateral non–instrument-assisted lumbar decompression and fusionSurgical Neurology, 2008
- Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatiteEuropean Spine Journal, 2005
- A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusionsEuropean Spine Journal, 2003
- Iliac Crest Bone Graft Harvest Donor Site MorbiditySpine, 1995